SCHEMBL27835006

SCHEMBL27835006

CC(C)(C)C(=O)ON1CCN(c2cc([N+](=O)[O-])cc(Br)n2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 1/20 0.38
▸ LMNA P02545 5/20 0.37
▸ MAPT P10636 4/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ HRH4 Q9H3N8 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ CASP4 P49662 1/20 0.33
▸ CASP5 P51878 1/20 0.33
▸ APAF1 O14727 1/20 0.32
▸ NSD2 O96028 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ CASP3 P42574 1/20 0.32
▸ SENP8 Q96LD8 1/20 0.32
▸ SENP7 Q9BQF6 1/20 0.32
▸ SENP6 Q9GZR1 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1580680 0.82 ALDH1A1 (0.59) KCNH2LMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL27815223 0.78 HTR6 (0.41) HRH4
SCHEMBL1579369 0.77 MAPT (0.40) LMNAMAPTALDH1A1HRH4MAPK1
SCHEMBL27729958 0.77 MAPT (0.58) LMNAMAPTALDH1A1KDM4EMAPK1
SCHEMBL27809069 0.76 GRIN2D (0.44) —
SCHEMBL27829476 0.76 CKS1B (0.35) ALDH1A1KDM4EMEN1KMT2ACYP1A2
SCHEMBL27714032 0.74 MAPT (0.64) LMNAMAPTALDH1A1GAASMN1; SMN2
SCHEMBL31396262 0.74 ALDH1A1 (0.42) KCNH2LMNAMAPTALDH1A1
SCHEMBL28785119 0.74 MAPT (0.46) LMNAMAPTALDH1A1MAPK1KMT2A
SCHEMBL28024438 0.73 MAPT (0.51) LMNAMAPTALDH1A1KDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102137856-A 2, 4' -bipyridine compounds as protein kinase D inhibitors useful for the treatment of IA heart failure and cancer NOVARTIS AG 2011-07-27 — — CN disclosed
Send feedback